Evidence map›Paper›PMID 39793521›Full record

ArticleMultiple sclerosis and related disorders2025

Retraction Notice to "New relapse of multiple sclerosis and neuromyelitis optica as a potential adverse event of AstraZeneca AZD1222 vaccination for COVID-19" [Multiple Sclerosis and Related Disorders 57 (2022) 103321].

Yara D Fragoso, Sidney Gomes, Marcus Vinicius M Gonçalves, Junior Euldes Mendes, Bianca Etelvina S de Oliveira, Cristiane Franklin Rocha, Gutemberg A Cruz Dos Santos, Carlos Bernardo Tauil, Raquel Vassao Araujo, Jean Pierre S Peron

Abstract readRetraction Notice
PubMed Full text at PMC Publisher
In one paragraph

Article in Multiple sclerosis and related disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Yara D FragosoMedical School, Universidade Metropolitana de Santos, UNIMES Avenida Conselheiro, Nebias 536, Santos, SP CEP 11045-002, Brazil.
Sidney GomesHospital Beneficencia Portuguesa de Sao Paulo, Sao Paulo, SP, Brazil.
Marcus Vinicius M GonçalvesUniversidade da Regiao de Joinville, Joinville, SC, Brazil.
Junior Euldes MendesPrivate Neurological Clinic, Montes Claros, MG, Brazil.
Bianca Etelvina S de OliveiraFundacao Centro Integrado de Apoio a Pessoa com Deficiencia, Joao Pessoa, PB, Brazil.
Cristiane Franklin RochaPrivate Neurological Clinic, Belo Horizonte, MG, Brazil.
Gutemberg A Cruz Dos SantosUniversidade Estácio de Sa, Universidade Federal Fluminense, Niteroi, RJ, Brazil.
Carlos Bernardo TauilUniversidade de Brasilia, Brasilia, DF, Brazil.
Raquel Vassao AraujoPrivate Neurological Clinic, Montes Claros, MG, Brazil.
Jean Pierre S PeronNeuroimmune Interactions Laboratory, Universidade de Sao Paulo, Sao Paulo, SP, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/policies/article-withdrawal). This article has been retracted at the request of the authors. The authors would like to express their deepest apologies for the error contained in their article and for any concerns or misunderstandings it may have caused. Specifically, the article mistakenly mentioned the presence of the MF59 adjuvant in the AZD1222 vaccine formulation, which is incorrect.

Identifiers

PMID39793521
PMCPMC12548781

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.